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Abstract
Cardiovascular disease (CVD) is increasingly becoming one of the largest contributors
to preventable death globally each year. This disease is predominately caused by poor
lifestyle choices such as unhealthy diet, inactivity, smoking and the harmful use of
alcohol. Modern treatments of CVD are often surgical and pharmaceutical which can be
both invasive and expensive and do not necessarily address the causation or
prevention of the disease. Research is now being done in preventative health to study
the effects that a healthy lifestyle has in both reducing and even reversing CVD.
Lifestyle intervention programs are a part of this preventative health phenomenon. This
study aims to explore the nature and effectiveness of the Coronary Health Improvement
Program (CHIP), in its ability to reduce CVD risk factors.
Data was collected from a set of volunteer-delivered CHIP programs that were
conducted in Hawera, New Zealand. The sample consisted of 284 participants who
responded voluntarily to local program advertising. Participants were given a blood
screening and questionnaire which was conducted at the commencement and
conclusion of the 30 day intervention. The blood screening was given to measure
baseline biometrics (BMI, total cholesterol, low density lipoprotein, high density
lipoprotein, triglycerides and glucose) and the questionnaire was a tool used to gather
information about the participants’ basic demographics, lifestyle, and family and medical
histories. The data was then analysed to determine changes in the blood screening
biometrics post intervention. Also these changes were further examined to determine
the impact, if any, of participants’ lifestyle and family medical histories. An analysis of
the nature of the program and its delivery was also conducted through interviews with
the program facilitator.
Participants’ blood screening results post intervention indicated a significant reduction in
their biometrics from the baseline scores with reductions of 4% to 23%. In particular,
participants who recorded high baseline figures recorded the most significant changes
after the 30 days. There were significant differences across gender, marital status and
age in the reduction of a number of the participants’ biometrics.
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This study provides valuable evidence suggesting that a volunteer-delivered, community
based, CHIP lifestyle education program is effective in improving the health of
participants and, in particular, reducing CVD risk factors. These findings will be
important for the designing and delivery of lifestyle education programs for the
prevention and treatment of CVD for the future.
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Chapter One
Rationale
The World Health Organization states that 63% of all global deaths in 2008 were a
result of non-communicable diseases (WHO, 2008). More specifically, 36 million out of
a total of 57 million deaths globally in 2008 were attributed to lifestyle diseases. The
four biggest killers were cardiovascular disease, cancer, respiratory diseases and
diabetes. These diseases mainly occur as a result of poor lifestyle choices, in particular
tobacco use, physical inactivity, unhealthy diet, and the harmful use of alcohol. It is
clearly evident that lifestyle disease is becoming a huge problem. Up until recently the
current paradigms for management of these diseases have been surgical and
pharmaceutical. This type of management is putting enormous pressure on the health
care systems. However the emergence of lifestyle medicine and prevention is
becoming increasingly widespread.

Lifestyle education programs are being developed in response to the emerging research
being done in this area of preventative health. Two programs in particular are currently
operating with great success in reducing CVD. They are the Pritikin Longevity Centre
and the Ornish Lifestyle Centre. Whilst the Pritikin and Ornish residential education
programs have proven to be effective in improving health for patients, they are very
costly and often inaccessible to some people who, for whatever reason, are unable to
stay in a residential facility. Another program, the Coronary Health Improvement
Program (CHIP) has demonstrated significant reductions in cardiovascular risk factors
(Englert et al. 2007). Whilst this program was initially designed by Dr. Hans Diehl for
1

people with coronary health issues, the program is being delivered to participants in
view to improve all aspects of health. The CHIP program aims to educate participants
on making lifestyle changes that involves a diet which is whole plant food based, with
little or no animal products. As well as modifying their nutrition, it also recommends
participants engage in at least 30 minutes of daily exercise. Identifying and
implementing ways to reduce stress and cease smoking is also part of the programs
guidelines for holistic health.
A volunteer delivered CHIP lifestyle education program mentioned above, has been
functioning in America for a number of years. It is a low cost and easily accessible
alternative to the residential based programs. A study of the results of these programs
was conducted with up to 4500 participants. These participants overall recorded
significant changes to their biometrics. The two most significant changes included an
11% decrease in total cholesterol and a 13% decrease in low density lipoprotein post
intervention. Analysis of this data from these CHIP programs indicated that this program
was effective in reducing cardiovascular risk factors (Rankin et al. 2012).

Whilst this study was conducted in an American context, no studies have determined
the effectiveness of the CHIP program within a New Zealand setting. Therefore, there is
a need to explore the effectiveness of the CHIP program in reducing CVD risk factors in
a New Zealand context. Further analysis of the nature of the delivery of this education
program is also required.

2

This case study aims to meet this need by accessing data from a series of volunteer
delivered CHIP programs that have taken place in the city of Hawera, New Zealand.

Research Question
This study is directed by the following research questions:
1) What are the key components of the volunteer delivered CHIP lifestyle education
program with reference to Hawera based programs?
2) How effective were the CHIP programs conducted in Hawera in reducing CVD risk
factors

of

the

participants?

And

further,

what

impact

does

participants

demographics, previous lifestyle patterns and initial health conditions have on these
outcomes?

Structure of the Thesis
This thesis consists of six chapters and is presented in the following manner. Chapter
one focuses on the purpose, rationale and aims for this study. It also identifies the
questions that the study attempts to answer. Chapter Two will discuss the relevant
literature relating to lifestyle education programs.

Chapter Three identifies the

methodologies chosen, including information on the sample and data analysis
processes.

Chapter Four will explore the nature of the program including program

delivery, team membership, advertising and community response. Chapter 5 discusses
the results in terms of overall data and specific analysis of biometrics categories. The
final chapter discusses the results outlined previously as well as identifying any

3

limitations and implications for future studies.
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Chapter Two
Literature Review
Introduction
Studies being done in the area of preventative health indicate poor lifestyle choices are
causing major diseases in individuals. One such article states that the world is feeling
the impact of a global chronic disease epidemic which it terms “diseases of comfort”
cause by poor lifestyle choices. (Choi et al., 2005)
Cardiovascular disease is one of these diseases that is responsible for millions of
deaths globally each year and yet it is largely preventable through lifestyle change. It is
important to therefore identify risk factors for cardiovascular disease and the lifestyle
changes that can be made to reduce and even reverse this killer.

Cardiovascular Disease
Cardiovascular disease (CVD) refers to diseases relating to the heart or blood vessels.
The World Health Organisation (WHO) report, published in September 2011, states that
CVDs are the leading cause of death and disability in the world. These statistics are
quite concerning, especially considering that many forms of CVDs are preventable
through simple lifestyle changes. The Framingham study which commenced in 1948
was the first study which identified the major risk factors for CVD. This study indicated
that cigarette smoke, increased cholesterol levels, elevated blood pressure, obesity and
inactivity were the major risk factors associated with CVD (O’Donnell & Elosua, 2008).

5

Since then, many studies have been done to identify the various risk and biometric
factors which contribute to CVD. As previously identified indicated tobacco use,
physical inactivity, unhealthy diet and harmful use of alcohol are the main risk factors to
these diseases (WHO, 2008). The INTERHEART study which was completed in 2004
and involved over 52 countries identified diabetes, hypertension, psychological factors
and a lack of consumption of fruit and vegetables as additional risk factors for CVD.
(Yusuf et al., 2004) These risk factors can be grouped into two categories; lifestyle
habits and biometric risk factors. The lifestyle related risk factors include; smoking,
diet, inactivity and mental health, whilst the biometric risk factors include cholesterol,
blood pressure, obesity and diabetes.

Lifestyle Related Risk Factors
Smoking
A study by Ambrose and Barua (2004) into the pathophysiology of cigarette smoking
and CVD identified that smoking in any form contributes to cardiovascular morbidity and
mortality. Burns (2003) attributes some 140,000 premature deaths that occur each year
to CVD from smoking. The effect of smoking on the cardiovascular system is clear and
studies have found that cigarette smoking predisposes the individual to several different
cardiovascular effects including; angina, acute coronary syndromes, sudden death and
stroke. (Ambrose & Barua 2004) Interestingly however the damage to the
cardiovascular system from smoking also relates to those who are exposed to cigarette
smoke through passive environmental smoking. Taylor, Johnson and Kazemi (1992)
identify the effects of environmental tobacco smoke as affecting cardiovascular function,
6

platelet function, neutrophil function and plaque formation which are all probable factors
leading to heart disease. Benowitz (2009) identifies that cessation of smoking at any
age can dramatically reduce these risks associated with smoking. However he goes on
to say that quitting is often difficult given the addictive nature of tobacco.

Diet
Reddy (2010) identifies that diet, and the nutrients that are consumed, are major
determinants which can initiate and influence the course of cardiovascular disease. A
poor dietary intake is related to a number of cardiovascular risk factors which can
include; hypertension, abnormal blood lipids and abdominal obesity (Yusef et al., 2004).
A cohort of studies done on nutrition and cardiovascular disease showed that a diet
consisted primarily of a high consumption of plant based foods (such as fruits,
vegetables, nuts and whole grains) was associated with significantly lower incidences of
coronary artery disease and stroke (Hu, 2003).

Physical Inactivity
An article written for the Cancer Journal for Clinicians (Eyre et al., 2004) argues that
there is evidence to suggest that physical activity reduces chronic disease risk both
directly in its impact on hormone levels and indirectly through its impact on weight
control. A statement from the Council on Clinical Cardiology (Subcommittee on
Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity,
and Metabolism (Subcommittee on Physical Activity) identified that habitual physical
activity not only can prevent the development of coronary artery disease but also reduce
7

the symptoms in patients who already have established coronary disease. In a study
conducted by Blair (2001) the greatest cardiovascular disease benefits were obtained
by those who exercised vigorously.

Mental Health
Whilst smoking, diet and physical activity are more commonly known risk factors for
cardiovascular disease, psychological factors are also contributors. In a study by Ford
and colleagues (1998), it was revealed that clinical depression was in fact an
independent risk factor for coronary heart disease. Yusuf (2004) also identified other
psychological factors such as prolonged stress and anxiety (which can lead to a state of
disequilibrium) over time can result in heart disease. Katon Lin & Kroenke (2007), in
analysing the results of 31 studies with 16922, patients identify that depression and
anxiety can be strongly associated with cardiovascular disease and other chronic
medical diseases.

Biometric Risk Factors
Cholesterol
Whilst cholesterol is important for normal body function, elevated cholesterol levels are
strongly linked with cardiovascular diseases (Krauss et al., 2000). Total cholesterol is
made up of low density lipoproteins (LDL) and high density lipoproteins (HDL). HDL is
considered to be very important for good health as it takes cholesterol away from the
cells and tissues and to the liver for excretion. The function of LDL is to take cholesterol
to the places it is required in the body. High levels of LDL however can result in a build8

up of cholesterol and cause hardening of artery walls leading to cardiovascular
diseases. Studies have found that a reduction in the level of LDL in the body can
decrease the risk of a cardiac event (Assmann, G, 1998: Wilson, Anderson, Castelli &
Kannel, 1991). It has also been suggested that an increase in HDL levels can decrease
the risk of a cardiac event (Brown et al., 2001).

Blood Pressure
High blood pressure is associated with an increased risk of cardiovascular disease
(Vasan et al., 2001). This risk factor increases as blood pressure reaches above
normal range, i.e. <120 systolic and <80mmHG diastolic. (Stamler, Stamler & Neaton,
1993). A study done to determine the impact of high normal blood pressure on
cardiovascular disease found that those with high normal blood pressure had an
increased risk of disease by 2.5% amoung women and 1.5% amoung men (Vasan et
al., 2001). Studies have concluded that adopting a healthy lifestyle eating plan and
reducing sodium consumption can lower blood pressure substantially (Sacks et al.,
2001).

Obesity
Sowers (1998) identifies obesity as a risk factor for cardiovascular disease. He found
that obesity can often lead to diseases such as diabetes and hypertension which can, in
turn, further contribute to the risk of cardiac disease. Obesity is a metabolic disorder.
The excess fat stored by the body in various places can in fact increase risk of coronary
artery diseases such as dyslipidemia, hypertension, glucose intolerance, inflammatory
9

markers, and the prothrombotic state (Poirier & Eckel, 2000). The results of a study to
identify the impact excess body weight had on CVD found that the increase in excess
body weight of individuals increased the prevalence of cardiovascular disease. For
individuals with a normal weight the prevalence of CVD was 20%, for overweight
individuals the rate increased to 28% and in obese individuals, 29% (Wang et al., 2002).

Diabetes
Diabetes is considered to be one of the major risk factors of CVD (Grundy et al., 1999).
One study identifies CVD as the cause of death for 65% of people with diabetes
(Gieuss, 1995). Individuals with type 2 diabetes are at a greater risk of cardiac disease
due to the likelihood of developing hyperglycemia, hypertension, and dyslipidemia
(Gaede et al., 2003).

Lifestyle Medicine: Key Players
Dean Ornish
Dr Dean Ornish is well known as one of the founders of preventative health. In 1977, Dr
Ornish discovered through research that lifestyle changes could stop and reverse
coronary heart disease and many other chronic diseases. These lifestyle changes
included eating a whole foods plant based diet, engaging in moderate exercise, ceasing
smoking and using stress management techniques such as yoga and meditation as well
as having psychosocial support (Ornish Spectrum, 2012). He and his colleagues
developed a program called ‘Dr Ornish’s Program For Reversing Heart Disease’ which
10

targets four basic lifestyle elements; what you eat, how much activity you have, how you
respond to stress and how much love and support you have. (Ornish Spectrum, 2012)
Dr Ornish outlines below the important role that lifestyle plays in individual health and
wellbeing.

“People often think that advances in medicine have to be a new drug, a new laser, or a
surgical intervention to be powerful—something really high-tech and expensive. They
often have a hard time believing that the simple choices that we make in our lives
each day—what we eat, how we respond to stress, whether or not we smoke, how much
we exercise and the quality of our relationships—can make such a powerful difference in
our health, our well-being, and our survival, but they often do” (Ornish Spectrum, 2012).

Caldwell Esselstyn
In 2007, Dr Esselstyn (who is an internationally known surgeon, researcher and clinician
at the Cleveland Clinic) wrote the book entitled; Prevent and Reverse Heart Disease.
He identified that patients who were treated surgically or pharmaceutically to reduce the
impact of symptoms but little preventative treatment was prescribed. After analysing the
results on a 20 year study on nutrition, Dr Esselstyn advocated that a strict vegan diet
can prevent and reverse heart disease. Dr Esselstyn outlines his idea of medicine as
being more than just surgical.
"Beyond surgery" does not mean one must relinquish the cherished burden of
operative responsibility, but it does imply that we must participate in the endeavor
to eliminate and prevent diseases by nonsurgical methods of lifestyle changes
(Esselstyn, 1991).
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Lifestyle Education Programs
Lifestyle education programs are being developed in response to the emerging research
being done in the area of preventative health. Two programs in particular are currently
operating with great success in this area. They are the Pritikin Longevity Centre and
the Ornish Lifestyle Centre.

Pritikin Longevity Centre
The Pritikin Longevity Centre was developed in the early 1980 by Nathan Pritikin. He
initially designed a 3 week residential lifestyle program. His program targets three main
areas; nutrition, exercise and mind body health. The nutrition involves eating minimally
processed plant foods such as fruits, vegetables and whole grains, as well as modest
amounts of non-fat dairy, soy and fish. Eating these types of foods as well as taking
regular exercise and minimising stress is the key message of the Pritikin Longevity
Centre. A study which was conducted on 4587 participants of the program recorded a
23% decrease in total cholesterol, 33% decrease in trigylcerides, and 23% decrease in
LDL cholesterol (Barnard, 1991).

Ornish Lifestyle Centre
As mentioned previously Dean Ornish developed a program that is aimed at targeting
lifestyle changes. This program divides all foods into a spectrum of choices. These
range from those choices which are very healthful (fruits, vegetables, grains) to those
which are least healthful (cakes, fried foods). However, with regards to reversing heart
disease specifically, Ornish has identified some specific guidelines including; limiting fat
12

intake to no more than 10%, a cessation of animal products except non-fat dairy
products, limiting sugar intake, a cessation of caffeine and limiting alcohol consumption.
Several studies have been done on this program to ascertain its effectiveness in
reversing heart disease. One particular study conducted with 48 patients (20 patients
were the control and the other 28 completed the lifestyle intervention program) indicated
a decrease in low density lipoprotein (LDL) of 37.2% compared with the control group of
1.2% after just one year. Also patients involved with the lifestyle changes recorded
fewer cardiac events in the 5 years post the intervention (Ornish et al., 1990).

CHIP Program
Whilst the Pritikin and Ornish residential education programs have proven to be
effective in improving health for patients, they are very costly and often inaccessible to
people who are unable to stay in a residential facility, due to commitments such as
family and work. A lifestyle education program which is run in the community has
proven to be a low cost and easily accessible program for people wanting to improve
their health and lifestyle. The Coronary Health Improvement Program (CHIP) has
demonstrated significant reductions in biometric risk factors (Englert et al. 2007).

Whilst other lifestyle intervention programs are professionally delivered, the CHIP
program has been designed to be delivered by a team of volunteers. These volunteers
participate in a weekend training program and are accredited to deliver the CHIP
program in their respective communities. The expertise is not provided by the leaders

13

of the program but rather through the viewing of the DVDs presented by the developer
of the program.

This intensive education program involves participants attending sixteen, 2 hour
sessions over a period of four to five weeks. These sessions aim to provide participants
with the knowledge and ability to make lifestyle changes to improve their health. The
educational pre-recorded lectures which are presented by Dr Hans Diehl, inform
participants about the causation of diseases and how lifestyle changes can prevent and
reduce these health concerns.

There have been over 20 articles on CHIP which have been published to date. A 2007
article, analysed data from over 1500 participants in five CHIP programs conducted in
Rockford, Illinios. The results indicated highly significant reductions in participants’
total cholesterol, LDL, triglycerides, blood glucose and blood pressure (Englert et al.,
2007). This article concluded that a well-designed community based education program
is effective in improving health for participants. (Englert et al., 2007)

One of the more recent articles which involved over 5000 CHIP participants similarly
demonstrated significant reductions in the participants’ body mass, blood pressure, total
cholesterol, low density lipoprotein, triglycerides and fasting plasma glucose. Of these
participants, those who were considered most at risk recorded the greatest
improvements to their health (Rankin et al., 2011).

14

It is evident that cardiovascular disease is a major problem and burden today. The
biometric and risk factors pertaining to these diseases have been well identified.
Lifestyle education programs such as CHIP have proven to be effective in achieving
positive changes to participant’s lifestyle through reductions of those risk factors. The
CHIP program, comparative to other intervention programs, is very effective with its low
cost, high accessibility and volunteer delivery.

15

Chapter Three
Methodology
Introduction
This chapter presents a rationale and description of the research orientation used in the
study. This study looks at the effectiveness of a volunteer delivered lifestyle education
program in reducing risk factors associated with cardiovascular disease. Limited
research has been conducted to ascertain the effectiveness of volunteer based delivery
of lifestyle education programs. But such studies have been based in the United States
and have accessed data from a number of delivery sites. The aim of this study is to
evaluate the effectiveness of a New Zealand based, volunteer-delivered program
conducted from a single site. To fulfil this aim, the research adopted a case study
approach, which was observational quasi-experimental and quantitative in its
orientation.
This study will explore the changes in participants’ biometrics risk factors (total
cholesterol, low density lipoprotein, high density lipoprotein, triglycerides and fasting
plasma glucose, BMI and blood pressure) pre and post involvement in a 30 day CHIP
program (refer to Chap 4). The biometric and demographic data taken from the CHIP
survey instrument and blood screening results recorded by the program co-ordinators
and will be accessed by the researcher. Participants consented to have their data
collected and used for research purposes. Access to the data was obtained with the
permission from the Lifestyle Medicine Institute (New Zealand).
16

Sample
Data will be sourced for this case study from seven programs run independently by
group leader Dr T in Hawera, NZ. Participation in the CHIP program is voluntary and is
as a response to formal and informal advertising conducted by the local CHIP team.
Each program was run under the leadership of Dr T and around five core support
personnel. Hawera is a rural town with a population of approximately 11,000 people
situated in dairy farming province of Taranaki.

Quantitative Measures
From the CHIP survey and blood screening process the demographic, biometric,
lifestyle habits, family story and medical history statistics will be determined.

Demographic Measures
Through the survey instrument, data will be collected relating to the participants general
demographic features of age, gender, marital status and religious affiliation.

Biometric Measures
Data will be obtained from blood samples collected from participants at the
commencement and conclusion of the CHIP program and sent to the pathology
laboratories for biometric analysis. This blood screening will include measures for total
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cholesterol, high density lipoprotein, low density lipoprotein, triglycerides, and fasting
blood glucose levels.

Other biometric measures that will be collected from the CHIP survey include: height,
weight and waist circumference. From this data the participants Body Mass Index (BMI)
will be calculated and recorded. Along with this the participants will have their systolic
and diastolic blood pressure taken pre and post intervention.
For each of the biometric measures identified, participants will be placed in respective
risk factor classification groupings.

Biometric Risk Factor Classifications
The National Cholesterol Education Program Adult Treatment Panel III classification
system 7 will be used to categorise participants for all risk factors excluding total
cholesterol (National Cholesterol Education Program, 2002). The Framingham
classification will be used for the stratification of the total cholesterol data (Wilson et al.,
1998). This classification identified five categories of cholesterol levels which allows for
a more detailed analysis to be made of the effects of the intervention for the highest risk
participants than the National Cholesterol Education Program Adult Treatment Panel III
classification system 7.
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Lifestyle Measures
Data will be obtained from the CHIP survey questions relating to specific lifestyle habits
such as exercise levels and smoking status both before and after the CHIP program to
determine lifestyle measures.

Family and Medical History Measures
Data will be obtained from the CHIP survey questions relating to the participants’ health
history and family history of cardiovascular disease and diabetes, in order to generate
family and medical history measures. In particular their histories of asthma, diabetes
and cardiac events will be accessed.

Data Analysis
The data from the CHIP survey and blood screening will be entered into the statistical
software package SPSS 17.0 (SPSS 17.0 for Windows, SPSS Inc). Descriptive
statistics for each measure and sub measure will be determined. Dependent and
Independent group t-tests and independent one way between groups ANOVA with posthoc comparisons will be run to locate any area of significant difference between
participant group or subgroup measures. Cohen’s d will be calculated to determine the
effect size of the CHIP intervention with respect to each of the measured biometrics for
participant groups and sub groups.
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Chapter Four
The CHIP Program
Elements Of The Program
CHIP stands for Coronary Health Improvement Program, but it involves much more than
the name suggests. Whilst the program was initially designed by Dr. Hans Diehl for
people with coronary health issues, the program is being delivered to participants in
view to improve all aspects of health. CHIP aims to educate participants on making
lifestyle changes that involve a diet which is whole plant food based, with little or no
animal products. As well as modifying their nutrition, it also recommends participants
engage in at least 30 minutes of daily exercise. Identifying and implementing ways to
reduce stress and ceasing smoking is also part of the programs guidelines for holistic
health.
Participants begin the program by fasting for 8 hours and undergoing a blood screening.
The blood sample is sent away to be analysed for cholesterol levels, (HDL, triglycerides,
total cholesterol and LDL) and fasting plasma glucose levels. The participants are also
weighed, their height is measured, their blood pressure tested and they have their
resting pulse recorded for further evaluative tests such as body mass index (BMI).
Participants are also required to complete a questionnaire which asks questions about
dietary and exercise habits, their past exposure/histories of smoking, obesity, diabetes,
high blood pressure, and cardiac events as well as common questions about age,
gender and religious affiliation. Another aspect of the questionnaire involves collecting
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information on the attendee’s family history of diabetes, cancer and coronary health.
This process is then repeated post-intervention to measure the participants’ progress.
Once the preliminary testing is completed, the face to face meetings commence. The
program consists of approximately 40 hours of face to face meetings conducted over a
period of 16 sessions, usually within a four or five week period of time. Each meeting
includes the viewing of a DVD, a cooking demonstration and a group discussion. Whilst
the meeting does not include an exercise component, participants are encouraged each
session with tips on how to exercise. One of the meetings also includes a shopping tour
where participants are shown how to make informed and effective dietary choices using
produce and groceries from their local supermarket.
The topics covered in the DVD viewing time and group discussion include:
•

modern medicine: its accomplishments and limitations

•

atherosclerosis

•

coronary risk factors

•

smoking

•

exercise

•

dietary fibre

•

cholesterol

•

the optimal diet

•

obesity

•

diabetes

•

hypertension
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•

hyperlipidaemia

•

lifestyle and health

•

behavioural change

•

self-worth (Englert, Diehl et al., 2004)

After the program is completed participants are given their final blood screening and
questionnaire and are encouraged to join the CHIP Alumnus which meets once a month
to keep participants informed and encouraged on maintaining their healthy lifestyle
choices.

Delivery
CHIP was designed to be conducted in a non- medical environment, delivered by
volunteer directors. This is made possible by supplying the directors with the DVD’s
which contain all the information presentations. This provides the essential information
needed for the team leaders to pass onto the participants at the meetings. In order to
equip these volunteer directors with the necessary tools to effectively conduct a CHIP
program, each volunteer is required to complete an intensive weekend of training. At
this training weekend volunteer directors are given materials and attend workshops
which teach them the skills necessary to deliver the CHIP program in their local area.
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Hawera Based CHIP Program
Dr T is the facilitator for the CHIP programs that were conducted in Hawera. The data
collected from these programs forms the basis for this case study. Dr T is a General
Practitioner who is passionate about preventative health. He completed training to be a
leader for the CHIP program at a weekend CHIP summit at the Gold Coast, Australia.
He has since conducted 7 CHIP programs in Hawera.

Team
There were a core team of helpers who assisted Dr T in delivering the CHIP program in
Hawera. The team for each program was different but was made up of approximately 5
core members and extra volunteers. These members were assigned various jobs,
including welcoming, data collection, kitchen help and technical support. Dr T was the
main presenter for each program. After the initial program was conducted, some
participants from that program volunteered to support Dr T in facilitating other programs.

Program Delivery
The number of participants for each of the seven programs varied from 15 to 100
participants. Dr T suggested that the smaller groups were more effective in achieving
group based discussion and more individualised attention for participants. There have
been over 300 people who have completed the CHIP program in the Hawera area
under his direction. The standard program delivery of 16 sessions in a 4 week period
was extended with additional meetings once a week for a further 8 weeks before the
graduation. This was done with the intention to support participants more in their
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lifestyle changes. The program delivery for the meetings included cooking
demonstrations and the viewing of the DVD and workbook materials that were supplied.
The cost for participants was $440 for couples and for singles $300. Participants were
given an option to pay a deposit and then pay the remainder of the fee in weekly
instalments.

Data Collection
The data from the questionnaires and blood tests was collected and entered into the
CHIP assistant computer program by Dr T and his wife.

Advertising
There were many different mediums of advertising used to promote CHIP in Hawera.
Pamphlets which were designed by Dr T were placed in strategic places such as
hospitals, doctor’s surgeries and noticeboards. Dr T visited the local Lions and Rotary
clubs and gave short presentations on CHIP to encourage support and awareness of
the program. Newspaper and radio advertisements were also used. Some patients of
Dr T were also encouraged to attend the CHIP meetings and were sent information
regarding upcoming programs in the area. He estimated about 50% of all participants
that attended the programs in Hawera were patients in his surgery. Dr T commented
that the best medium of advertising was word of mouth from previous CHIP participants.
He said that word of mouth along with the newspaper advertisements were the most
beneficial in bringing participants to the program.

24

Community Response
Dr T indicated that the community response towards the program had been very
positive. A visit from Dr Hans Diehl, the creator of the program was very effective in
generating interest in Hawera about CHIP. In addition, the local newspaper had written
a feature article in the weekend edition which also generated a good response from the
community.

Strengths and Weaknesses
Upon reflection of the CHIP programs, DR T, identified two main weaknesses which
required further attention. Firstly, the duration of each nightly meeting needed to be
shortened. The guidelines for running a CHIP program indicate the evening sessions to
run for two and half hours however Dr T identified this as being too long for the
participants and therefore adjusted it accordingly. The meetings each night were
reduced to one and a half hour sessions. Another difficulty that was identified was in
relation to the entry of data from the participants. Dr Hurlow found that the CHIP
assistant computer program was not user friendly and there were therefore many
difficulties experienced in entering the data. He concluded that a review of this program
needed to be conducted to prevent future complications. Despite these small setbacks,
he found the programs to be an extremely positive event for the community.
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The Educational Orientation of The CHIP Program
There are many elements that contribute towards the success or failure of an education
program. The participants’ ability to acquire knowledge and skills, make behaviour
changes where applicable and achieve measurable results are just some of the
important elements that are required. The CHIP program conducted by Dr T and his
team in Hawera involved the following key elements.

Motivation
Participants in this program were self-selected through an individual response to various
advertising mediums. The fact the people from the community chose to participate in
this program indicates a high level of motivation in achieving personal goals. This
motivation is a key factor in the success of the program.

Reputable Leadership
The CHIP program was conducted by a local family medical practitioner. His rapport
within the community for the work he does in his general practise, as well as being a
medical doctor, contributed to the effectiveness of the program. In general, participants
respond well when they have trust in the knowledge and skills of the leadership and the
team.

CHIP Support Team
Some of the members of the community who had previously completed the CHIP
program subsequently chose to become involved in the delivery of the new programs.
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These previous participants were an invaluable resource as they encouraged the new
group just beginning their journey. All of the team members, including the group
facilitator, volunteered their time and effort into conducting these programs. One of the
many benefits of this volunteer based delivery is the passion that leaders have in
educating the community to live healthier lives. Participants may find it easier to
approach the team leaders and ask questions because they know they are volunteering
their time and are therefore willing to help.

Practical Skills
As well as delivering information and knowledge to participants, this program aimed to
provide practical applications through cooking demonstrations and tastings. This
process enabled participants to see how to prepare healthy foods for themselves and
their families. One of the meetings involved a trip to the local supermarket to show
participants how to source local produce and products that are healthy. In addition, they
were given recipe books as part of their CHIP literature and the leadership team
demonstrated recipes from this book at each meeting. These simple lessons provided
opportunities for participants to gain the skill sets required in sourcing and producing
healthy food.

Literature
Participants were given a workbook, as well as other materials, that they could use to
gather more information. The workbooks provided a written way to apply their
knowledge by answering questions and engaging in group dialogue with the responses.
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This technique can provide enriched learning experiences for participants as they
contribute ideas and information.

Positive Reinforcement
Positive reinforcement is essential in developing and sustaining good habits (Elder et
al., 1999). Participants are continually given positive reinforcement from their team
leaders, as well as each other during the course of the program. This is done in
response to feedback about meals cooked at home and exercise activities the
participants engaged in. In particular the re-testing which is conducted at the end of the
program gives participants feedback on the changes they have made. These results
offer a practical measurement of improvements and success during the course of the
program. Finally, all participants who finish the group attend a graduation ceremony
where, once again, the positive results they have achieved are celebrated by the group.

Alumni
Once participants graduate from the program they are invited to be a part of the CHIP
Alumni which aims to help participants maintain their focus on living a healthy lifestyle.
The ability to be able to seek continual support from other participants and leaders as
they make lifelong changes can have a significant impact on their success.

Whilst the results of this program indicate success in improving the health of
participants in many areas, further research is required to ascertain the long term
effectiveness. No studies have been done yet to determine whether or not participants
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have continued applying the knowledge that they were taught after the program
concluded.
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Chapter Five
Results
Sample
The sample consisted of 284 participants with a mean age of 59.17 years and a
standard deviation of 11.19 years. 65.1% of this population were female (185) and
34.9% were male (99). The age distribution for each gender is illustrated in Figure 1.0.

Figure 1.0 The distribution of participants ages for both males and females.

The marital status of the participants is shown below in Figure 2.0: 5.6% were single,
79.6 were married, 4.9% were divorced and 4.9% were widowed.
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Figure 2.0 The distribution of the participants marital status.

Of the participants 9.2% reported a previous family history of cardiovascular disease
mortality, and 3.2% a family history of diabetes myelitis, 2.1% had a previous history of
stroke, 0.7% a previous history of heart failure and 3.5% a history of bypass.

Change in Biometrics
Combined Data
The mean absolute and percentage changes from baseline to post intervention in the
selected biometrics (weight, body mass index, systolic blood pressure, diastolic blood
pressure, total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides,
fasting plasma glucose) were calculated (Table 1). The distribution of these changes
for each biometric was tested for normality. The change distribution for all the
respective biometrics were found to be either normal or near normal. Paired t-tests
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were then calculated for each of the respective biometrics to determine if the changes
were statistically significant.
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Table 1: Mean changes in selected chronic diseases risk factors (biometrics) from baseline to post-intervention.

Baseline

Postintervention

Factor

N**

Mean (SD)*

Mean (SD)*

Mean
Change

% Change

t statistic

p value

Cohen’s d

Weight (kg)

284

88.29 18.78

84.50 17.77

-3.78

-4.21

28.64

<0.001

0.207

Body mass index (kg/m2)

284

31.86 6.36

30.51 6.10

-1.35

-4.22

30.48

<0.001

0.216

Systolic blood pressure (mmHg)

284

131.93 14.72

124.85 13.10

-7.08

-4.86

9.78

<0.001

0.508

Diastolic blood pressure (mmHg)

284

77.24 10.94

73.20 10.45

-4.04

-4.38

6.72

<0.001

0.377

Total cholesterol (mmol/L)

284

5.30 1.09

4.32 1.00

-.96

-18.09

25.62

<0.001

0.936

Low density lipoprotein (mmol/L)

284

3.30 .96

2.53 .86

-.77

-22.79

23.23

<0.001

0.844

High density lipoprotein (mmol/L)

284

1.29 .33

1.17 .28

-.13

-8.66

12.40

<0.001

0.392

Triglycerides (mmol/L)

284

1.55 .81

1.38 .65

-.17

-4.60

4.65

<0.001

0.231

Fasting plasma glucose (mmol/L)

284

5.96 1.62

5.48 .96

-.48

-5.67

6.44

<0.001

0.360

*SD – Standard deviation. **N – Number of participants
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There was statistically significant lowering of all the biometric risk factors with the
greatest change in low density lipoprotein (22.79%) and total cholesterol (18.09%)
(Table 1). Even though the weight change was significant at the .001 level it was the
smallest percentage change (4.21%) of the biometrics measured and even so is still
clinically significant. This lower change is probably due to the short time period of the
intervention and there is normally a time lag between change of lifestyle patterns and
weight change.
The effect size of the change for each biometric was determined using Cohen’s d;
where values around 0.2 indicate a small change, values around 0.5 indicate a
moderate change and values around 0.8 indicate a large change. Both total cholesterol
and low density lipoprotein recorded a large change with Cohen’s d values of 0.936 and
0.844 respectively. Systolic and diastolic blood pressure, high density lipoprotein, and
fasting plasma glucose recorded moderate changes with Cohen’s d values of 0.508,
0.377, 0.397, 0.360, whilst weight, body mass index and triglycerides recorded a small
change in Cohen’s d values of 0.216 and 0.231.
The lifestyle intervention program resulted in significant reductions across all the
biometric risk factors measured: weight, body mass index, systolic blood pressure,
diastolic blood pressure, total cholesterol, low density lipoprotein, high density
lipoprotein, triglycerides and fasting plasma glucose. These reductions were greatest for
low density lipoprotein and total cholesterol. The reduction recorded for weight, body
mass index and triglycerides were small comparative to the changes in the other risk
factors, however, they were still significant at the 0.001 level.
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These results indicate that these Hawera volunteer-delivered 30 day CHIP based
lifestyle intervention programs were effective in reducing biometrics and thus lowering
the potential risk of cardiovascular disease.
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Stratified Data
The biometric data was further analysed by first stratifying the data for each biometric in
terms of initial risk condition categories, using ‘The National Cholesterol Education
Program Adult Treatment Panel III, 2002’ convention or the Framingham Classification.
Each participant’s initial (baseline) reading for the respective biometric groups was
categorised according to this convention, from lowest to highest risk (Table 2). Body
mass index was divided into 3 risk categories: 18.5 - 24.9 kg/m2, 25 – 30 kg/m2 and >30
kg/m2. Systolic Blood Pressure was divided into 4 risk categories: <120, 120-139, 140160 and >160. Diastolic Blood Pressure was divided into 4 risk categories: <80, 80-89,
90-100 and >100. Total Cholesterol was divided into 5 risk categories: <4.00, 4.005.20, 5.21-5.99, 6.00-6.99 and >7.00. Low density lipoprotein was divided into 4 risk
categories: <2.50, 2.50-2.99, 3.00-4.00 and >4.00. High density lipoprotein was divided
into 3 risk categories: <1.00, 1.00-1.55, >1.55. Triglycerides were divided into 3 risk
categories: <1.00, 1.00-2.25 and >2.25. Finally fasting plasma glucose was also
divided into 3 risk categories: <5.60, 5.60-7.00 and >7.00.
For each risk category across all the biometrics, a paired t-test was performed to
determine whether there was a significant reduction in the post intervention results due
to the lifestyle change. Initially the percentage change (reduction or increase) for each
risk category across all biometrics were calculated and then for each change the effect
size was estimated using Cohen’s d (Table 2). The percentage of the sample within
each risk category was calculated for baseline and post intervention to enable an
analysis of the change in risk category numbers due to the lifestyle education
intervention.
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Table 2: Changes in chronic disease risk factor levels within 30 days according to initial risk factor classification.

N

N

Baseline

Post-intervention

Mean

% Mean

Baseline

Postintervention

Mean (SD)

Mean (SD)

Change

Change

p

t

Cohen’s
d

18.5 - 24.9

33 (11.6%)

42 (15.1%)

23.37 1.23

22.54 1.23

-0.83

-3.55%

<0.001

9.458

.674

25 – 30

93 (32.8%)

108 (38.7%)

27.85 1.42

26.66 1.36

-1.19

-4.27%

<.001

21.550

.855

157 (54.4%)

129 (46.23%)

36.02 5.44

34.47 5.28

-1.55

-4.30%

<.001

23.731

.289

<120

59 (20.77%)

109 (38.38%) 111.69 6.86

113.28 9.57

1.59

1.42%

>.208

-1.274

-0.190

120-139

150 (52.81%) 139 (48.94%) 130.78 4.80

124.57 10.84

-6.21

-4.75%

<.001

6.725

0.741

140-160

70 (24.64%)

34 (11.97%)

148.61 6.52

133.37 11.31

-15.24

-10.25%

<.001

12.465

1.651

5 (1.76%)

2 (.704%)

171.80 10.42

150.4 12.48

-21.4

-12.46%

>.005

5.570

1.861

Risk Factor
Body mass index (kg/m2)

> 30
Systolic blood pressure (mmHg)

>160
Diastolic blood pressure (mmHg)
<80

156 (54.92%) 199 (70.07%)

69.50 7.01

68.13 7.832

-1.37

-1.97%

>.876

.156

0.184

80-89

92 (32.39%)

74 (26.05%)

74.67 2.654

76.51 2.851

1.84

2.46%

<0.001

7.221

-0.668

90-100

31 (10.91%)

11 (3.873%)

92.61 2.89

80.35 13.27

-12.26

-13.23%

<.001

5.285

1.2

5 (1.76%)

0

109.00 4.63

86.60 4.27

-22.4

-20.55%

<.001

10.161

.76

>100
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N

N Post

Baseline

Post-intervention

Mean

% Mean

Baseline

Intervention

Mean (SD)

Mean (SD)

Change

Change

p

t

Cohen’s
d

25 (8.80%)

102 (35.91%)

3.31 .424

2.83 .577

-0.48

-14.50%

<.001

4.633

.948

4.00–5.20

111 (60.32%) 136 (47.88%)

4.62 .342

3.80 .529

-0.82

-17.75%

<.001

18.288

1.840

5.21–5.99

67 (23.59%)

27 (9.50%)

5.60 .203

4.59 .575

-1.01

-18.0%

<.001

14.518

2.342

6.00–6.99

66 (23.23%)

17 (5.98%)

6.36 .299

5.08 .754

-1.28

-20.12%

<.001

13.840

2.231

15 (5.28%)

2 (0.70%)

7.54 .403

6.06 .940

-1.48

-19.63%

<.001

7.266

2.047

<2.50

64 (22.53%)

152 (53.52%)

2.04 .493

1.57 .520

-0.48

-23.03%

<.001

9.795

0.928

2.50-2.99

47 (16.55%)

54 (19.01%)

2.80 .144

2.21 .383

-0.59

-21.07%

<.001

9.739

2.039

3.00-4.00

104 (36.61%)

64 (22.53%)

3.47 .290

2.67 .512

-.08

-23.05%

<.001

16.860

1.923

>4.00

69 (24.29%)

14 (4.92%)

4.539 .415

3.44 .702

-1.099

-24.21%

<.001

13.566

1.906

<1.00

56 (19.71%)

87 (30.63%)

.874 .907

.860 .115

-0.14

-1.60%

.33

.977

0.021

1.00-1.55

162 (57.04%) 169 (59.50%)

1.25 .160

1.14 .179

-.011

-8.8%

<.001

10.384

0.648

>1.55

66 (23.23%)

1.76 .168

1.49 .229

-0.27

-15.34%

<.001

10.234

1.344

Risk factor
Total cholesterol (mmol/L)
< 4.00

>7.00
Low density lipoprotein (mmol/L)

High density lipoprotein (mmol/L)

28 (9.85%)
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N

N Post

Baseline

Post-intervention

Mean

% Mean

Baseline

Intervention

Mean (SD)

Mean (SD)

Change

Change

p

t

Cohen’s
d

<1.00

77 (27.11%)

89 (31.33%)

.799 .140

.889 .277

0.09

11.56%

.001

-3.445

-0.410

1.00-2.25

162 (57.04%) 172 (66.56%)

1.50 .309

1.40 .503

-0.1

-6.66%

.008

2.666

0.239

>2.25

45 (15.84%)

2.99 .825

2.10 .854

-0.89

-29.76%

<.001

6.150

1.059

Risk factor
Triglycerides (mmol/L)

23 (8.09%)

Fasting plasma glucose (mmol/L)
<5.60

147 (51.76%) 194 (68.30%)

5.13 .373

5.07 .377

-0.06

-1.16%

.098

1.665

0.159

5.60-7.00

105 (36.97%)

74 (26.05%)

5.99 .385

5.53 .461

-0.46

-7.68%

<.001

10.458

1.083

>7.00

32 (11.26%)

16 (5.63%)

9.65 2.33

7.17 1.81

-2.48

25.7%

<.001

5.016

1.188

SD – Standard deviation.
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There were significant reductions due to the intervention across nearly all the risk
categories for each of the biometrics studied. However, participants in the lowest risk
factor categories for the systolic and diastolic blood pressure, high density lipoprotein
and fasting plasma glucose biometrics did not register a significant change between the
baseline and post intervention readings. For all other categories in these biometrics
there was a significant change at the 0.05 level. For body mass index, total cholesterol,
low density lipoprotein and triglycerides there were significant reductions across all the
risk factor categories.

With respect to the risk factor levels for each biometric there was a trend in terms of
percentage change post intervention where the participants in the highest risk factor
levels most often recorded the greatest percentage reduction. In general as the
participants’ risk factor increased, the percentage change in the respective biometrics
also increased. However there were some instances where the top two risk factor
levels recorded similar percentage changes rather than continuing to increase.

For diastolic blood pressure, total cholesterol, low density lipoprotein, triglycerides and
fasting plasma glucose the percentage change recorded for the highest risk factor level
ranged from 19 to 29%. Whereas the percentage change for the lowest risk factor
levels for most of the biometrics ranged from around 1 to 4%.
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The size of the pre to post change across the chronic disease baseline risk factor
levels were analysed using a Cohen’s d. This calculation was done to ascertain the
CHIP intervention effect size across these factor levels. A Cohen’s d effect size of .2
would be considered small, .5 moderate and >.8 is large. There was a trend across
the majority of the demographics where the effect size increased as the baseline
factor levels increased. There was however a few of the factor groups that had
slightly different results from the other groups. The effect size for the change in total
cholesterol is the greatest across all the initial risk factor levels. Its distribution of
change across the respective risk factors is different in that the effect size increases
with each level but peaks at the third level (5.21-5.099) at 2.342 and then starts to
reduce again. A possible reasoning for this phenomenon could be that the total
amount of cholesterol change that can occur in a month has been reached. Also,
the last category is unbound (no upper limit) so you have the potential for a very
large standard deviation and this may impact on the effect size for this category.
Therefore the continuation of these effects may not be seen over this intervention
time but may be seen post intervention. The effect size for BMI is relatively small
however when compared to the other biometrics. This is not unexpected as a
significant weight loss would not normally be recorded within the 30 days. This could
be one of the contributing factors to the smaller effect size results for this biometric.
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Demographic Differences in Biometric Changes
Introduction
This section explores the differences in the changes due to the CHIP intervention in
the respective biometrics across the following demographics: Gender, Age, Marital
Status, Family History of Cardiovascular Disease, Family History of Diabetes, Post
Intervention Exercise Change, Baseline Smoking Status and Baseline Biometrics.

Change in Body Mass Index (BMI)
Gender
There was a significant difference between the mean change in BMI for the males (M
= -1.560, SD = .893) when compared with the females (M = -1.243, SD = .633).
[t (282) = -3.468, p = .001]. The male participants recorded a larger mean change
post intervention compared with the female participants.

Age
The mean change in BMI values due to CHIP intervention across the various age
groupings are shown in Table 3.0. Post hoc tests indicated significance in the 50-59
and the 60-69 age categories [F (3,283) = 2.717, p <.045].
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Table 3.0: Age Change in BMI Values across Age Groups

Age Group

Number

Mean Change (M)

Standard Deviation (SD)

20-49

52

1.286

.770

50-59

80

1.553

.834

60-69

109

1.281

.701

70-80+

43

1.248

.614

The BMI change for the 0-49, 60-69 and 70+ years age groups were similar but the
50-59 years age group recorded a significantly larger change (Figure 3.0 Age – the
negative for the mean indicates a reduction in biometric post-intervention).

Figure 3.0: The Distribution of BMI Change across Age Groups
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Marital Status
There were no significant differences in the mean change in BMI across the various
marital status categories. (Table 3.1 Marital Status)
Table 3.1: Change in BMI Values across Marital Status Categories

Marital Status

Mean (M)

Standard Deviation (SD)

Single

-1.22

.702

Married

-1.37

.783

Divorced

-1.67

.493

Widowed

-1.14

.444

Family History of Cardiovascular Disease
There was a significant difference between the mean change in BMI for those with
(M = .-1.695, SD = 1.025) or without (M = -1.319, SD = .721) a family history of
cardiovascular disease. Post hoc tests indicated that those participants with a family
history of cardiovascular disease had a greater mean change than those with no
family history. [t (246) = -2.397, p <.017]
Family History of Diabetes
There was no significant differences between the mean change in BMI for those with
(M = -1.330, SD = .889) or without (M = -1.344, SD = .756) a family history of
diabetes.
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Baseline Exercise Levels
The mean change in BMI values due to CHIP intervention across the various
baseline exercise levels are shown in Table 3.2 Baseline Exercise Levels. Analysis
indicated that there were significant differences in the mean change in BMI across
baseline exercise categories [F (3,279) = 4.415, p <.005].

Table 3.2: Change in BMI Values across Baseline Exercise Levels
Exercise Level

Mean (M)

Standard Deviation (SD)

None

-1.55

.780

Mild

-1.35

.805

Moderate

-1.18

.602

Vigorous

-1.00

.512

The higher the participants’ exercise level at baseline the less change that was
recorded post intervention (Figure 3.1 Exercise Level).

Figure 3.1The Distribution of BMI Change across Baseline Exercise Levels
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Post Intervention Exercise Change
The mean change in BMI values due to CHIP intervention across the various post
intervention levels are shown in Table 3.3 Post Intervention Exercise Levels.
Analysis indicated that there were significant differences in the mean change in BMI
across post intervention exercise categories [F (3,275) = 4.332, p <.005].
Table 3.3: Change in BMI Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

-1.576

.692

-2

95

-1.508

.716

-1

105

-1.217

.840

0

48

-1.181

.513

As the participants increased their levels of exercise from baseline, their reduction in
BMI increased (Figure 3.2).
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Figure 3.2: The Distribution of BMI Change across Post Intervention Exercise Levels

Baseline Smoking Status
The mean change in BMI values due to CHIP intervention across the various
smoking status categories are shown in Table 3.4 Smoking Status. There were no
significant differences in the mean change in BMI across the various baseline
smoking status categories.
Table 3.4: Change in BMI Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

-1.31

.693

Ex-Smoker

-1.36

.728

Smoker

-1.27

.800

Live with Heavy Smoker

-1.92

1.507
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Baseline Biometric (BMI)
The mean change in BMI values due to CHIP intervention across the baseline BMI
risk level categories are shown in Table 3.5 Baseline BMI. Analysis indicated that
there were significant differences in the mean change in BMI across the various BMI
risk level categories [F (2,283) = 17.655, p <.001].
Table 3.5: Change in BMI Values across Baseline Biometric
Baseline BMI

Number

Mean (M)

Standard Deviation (SD)

Normal (18.5 – 24.9kg/m2)

33

-.8317

.505

Overweight (25-30kg/m2)

93

-1.1914

.533

Obese (>30kg/m2)

157

-1.550

.818

Those participants with the greatest baseline BMI reading reported the greatest
lowering of their BMI post intervention (Figure 3.3).

Figure 3.3: The Distribution of BMI Change across Baseline BMI
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When comparing the change in BMI levels (post intervention) across the various
demographics, there were 7 areas where a significant difference was recorded;
gender, age, family cardiovascular history, baseline biometrics, exercise level 1 and
exercise change. The male participants recorded a higher level of change to their
BMI than the female participants. The age categories of 50-59 and 60-69 recorded a
greater change then the other age groupings for their BMI. Those participants with a
family history of cardiovascular disease recorded a greater change in their BMI post
intervention than those without a family history. Those participants with the greatest
baseline BMI reading reported the greatest lowering of their BMI post intervention.
Those participants who had a baseline exercise level of none and had increased
their physical activity to moderate or vigorous during the intervention recorded the
most significant lowering of the BMI score post intervention.

Change in Blood Pressure Systolic (BP SYS)
Gender
There was no significant differences between the mean change in BP SYS for the
males (M = 8.21, SD = 12.229) when compared with the females (M = .721, SD =
.530).
Age
There were no significant differences in the mean change in BP SYS across the
various age groupings. (Table 4.0)
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Table 4.0: Change in BPSYS Values across Age Groups
Age Group

Mean (M)

Standard Deviation (SD)

20-29

.75

6.397

30-39

3.25

12.174

40-49

5.81

11.664

50-59

8.20

12.168

60-69

8.39

11.383

70-79

3.44

15.551

80+

8.00

10.124

Marital Status
There were no significant differences in the mean change in BP SYS across the
various marital status categories. (Table 4.1)

Table 4.1: Change in BPSYS Values across Marital Status Groups
Marital Status

Mean (M)

Standard Deviation (SD)

Single

7.50

9.805

Married

7.60

12.246

Divorced

5.36

10.609

Widowed

1.36

13.659
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Family History of Cardiovascular Disease
There was no significant differences between the mean change in BP SYS for those
with (M = 9.19, SD = 15.922) or without (M = 7.10, SD = 11.927) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in BP SYS for those
with (M = 13.00, SD = 14.500) or without (M = 7.13, SD = 12.283) a family history of
diabetes.
Baseline Exercise Levels
There were no significant differences in the mean change in BP SYS across the
various baseline exercise categories. (Table 4.2)
Table 4.2: Change in BPSYS Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

6.69

11.830

Mild

6.43

13.614

Moderate

7.70

11.056

Vigorous

6.50

9.477

Post Intervention Exercise Change
There were no significant differences in the mean change in BP SYS across the
various post intervention exercise change levels. (Table 4.3)
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Table 4.3: Change in BPSYS Values across Post Intervention Exercise Levels
Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

2.21

12.621

-2

95

7.40

11.911

-1

105

6.55

12.120

0

48

7.94

11.566

1

1

24.00

2

1

31.00

Baseline Smoking Status
There were no significant differences in the mean change in BP SYS across the
various baseline smoking status categories. (Table 4.4)
Table 4.4: Change in BPSYS Values across Baseline Smoking Status Categories
Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

6.46

11.775

Ex-Smoker

7.30

13.752

Smoker

7.00

11.874

Live with Heavy Smoker

9.78

13.944

Baseline Biometric: BP SYS
The mean change in BP SYS values due to CHIP intervention across the baseline
BP SYS risk level categories are shown in Table 4.5. Analysis indicated that there
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were significant differences in the mean change in BP SYS across the various BP
SYS risk level categories [F (3,284) = 29.962, p <.001].
Table 4.5: Change in BPSYS Values across Baseline Biometric
Baseline BP SYS

Number

Mean (M)

Standard Deviation (SD)

<120

59

-1.59

9.603

120.1 - 139

150

6.21

11.304

140-160

70

15.24

10.231

>160

5

21.40

8.591

Those participants with the greatest baseline BP SYS reading reported the greatest
lowering of their BP SYS levels post intervention. (Figure 4.0)

Figure 4.0: The Distribution of BP SYS Change across Baseline BP SYS
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When comparing the change in BP SYS (post intervention) across the various
demographics, only the baseline BP SYS registered a significant difference. In this
situation those participants with the greatest BP SYS pressure reading reported the
greatest lowering of their BP SYS levels post intervention.

Change in Blood Pressure Diastolic (BP DIA)
Gender
There was no significant differences between the mean change in BP DIA for the
males (M = 4.161, SD = 9.909) when compared with the females (M = 3.968, SD =
10.265).
Age
There were no significant differences in the mean change in BP DIA across the
various age groupings. (Table 5.0)
Table 5.0: Change in BP DIA Values across Age Groups
Age Group

Mean (M)

Standard Deviation (SD)

20-29

-1.500

6.806

30-39

4.666

11.452

40-49

4.361

11.151

50-59

3.225

10.434

60-69

4.779

9.978

70-79

2.558

9.468

80+

8.111

6.153
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Marital Status
There were no significant differences in the mean change in BP DIA across the
various marital status categories. (Table 5.1)

Table 5.1: Change in BP DIA Values across Marital Status Categories
Marital Status

Mean (M)

Standard Deviation (SD)

Single

3.875

8.898

Married

4.508

10.479

Divorced

1.785

5.767

Widowed

1.214

8.059

Family History of Cardiovascular Disease
There was no significant differences between the mean change in BP DIA for those
with (M = 4.846, SD = 10.212) or without (M = 4.301, SD = 10.261) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in BP DIA for those
with (M = 5.667, SD = 9.797) or without (M = 4.426, SD = 10.260) a family history of
diabetes.
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Baseline Exercise Levels
There were no significant differences in the mean change in BP DIA across the
various baseline exercise categories. (Table 5.2)
Table 5.2: Change in BP DIA Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

3.814

10.805

Mild

4.096

10.582

Moderate

3.963

9.214

Vigorous

3.285

8.597

Post Intervention Exercise Change
There were no significant differences in the mean change in BP DIA across the
various post intervention exercise change levels. (Table 5.3)

Table 5.3: Change in BP DIA Values across Post Intervention Exercise Change Levels
Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

.714

10.366

-2

95

3.652

9.250

-1

105

4.295

10.616

0

50

5.5400

10.167
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Baseline Smoking Status
There were no significant differences in the mean change in BP DIA across the
various baseline smoking status categories. (Table 5.4)

Table 5.4: Change in BP DIA Values across Baseline Smoking Status Levels
Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

3.689

9.757

Ex-Smoker

3.787

11.001

Smoker

10.333

15.612

Live with Heavy Smoker

3.888

6.972

Baseline Biometric: BP DIA
The mean change in BP DIA values due to CHIP intervention across the baseline BP
DIA risk level categories are shown in Table 5.5. Analysis indicated that there were
significant differences in the mean change in BP DIA across the various BP DIA risk
level categories [F (3,284) = 29.574, p <.001].
Table 5.5: Change in BP DIA Values across Baseline Biometric
Baseline BP DIA

Number

Mean (M)

Standard Deviation (SD)

Normal <80

156

.096

7.700

Pre-hypertensive 80-89

92

6.945

9.226

High 90-100

31

12.258

12.915

Dangerous >100

5

22.400

4.929
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Those participants with the greatest BP DIA pressure reading reported the greatest
lowering of their BP DIA levels post intervention. (Figure 5.0)

Figure 5.0: The Distribution of BP DIA Change across Baseline BP DIA

When comparing the change in BP DIA (post intervention) across the various
demographics, only the baseline BP DIA registered a significant difference. In this
situation those participants with the highest BP DIA readings reported the greatest
lowering of their BP DIA levels post intervention.

Change in Total Cholesterol (All values given in mmol/L)
Gender
There was no significant differences between the mean change in total cholesterol
for the males (M = 1.074, SD = .680) when compared with the females (M = .922, SD
= .615).
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Age
There were no significant differences in the mean change in total cholesterol across
the various age groupings. (Table 6.0)
Table 6.0: Change in Total Cholesterol Values across Age Groups
Age Group

Mean (M)

Standard Deviation (SD)

20-29

1.025

.512

30-39

1.008

.918

40-49

.863

.613

50-59

1.132

.665

60-69

.9606

.616

70-79

.850

.562

80+

.622

.589

Marital Status
There were no significant differences in the mean change in total cholesterol across
the various marital status categories. (Table 6.1)
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Table 6.1: Change in Total Cholesterol Values across Marital Status
Marital Status

Mean (M)

Standard Deviation (SD)

Single

.800

.419

Married

.976

.637

Divorced

1.092

.719

Widowed

.871

.785

Family History of Cardiovascular Disease
There was no significant differences between the mean change in total cholesterol
for those with (M = 1.038, SD = .485) or without (M = .949, SD = .640) a family
history of cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in total cholesterol
for those with (M = .566, SD = .447) or without (M = .967, SD = .630) a family history
of diabetes.
Baseline Exercise Level
There were no significant differences in the mean change in total cholesterol across
the various baseline exercise categories. (Table 6.2)
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Table 6.2: Change in Total Cholesterol Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

.987

.710

Mild

.903

.601

Moderate

1.050

.648

Vigorous

.965

.552

Post Intervention Exercise Level Change
There were no significant differences in the mean change in total cholesterol across
the various post intervention exercise change levels. (Table 6.3)
Table 6.3: Change in Total Cholesterol Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

1.000

.673

-2

95

1.018

.598

-1

105

.949

.633

0

48

.918

.745

1

1

2.100

Baseline Smoking Status
There were no significant differences in the mean change in total cholesterol across
the various baseline smoking status categories. (Table 6.4)
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Table 6.4: Change in Total Cholesterol Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

.993

.617

Ex-Smoker

.977

.729

Smoker

.644

.477

Live with Heavy Smoker

.911

.645

Baseline Total Cholesterol
The mean change in Total Cholesterol values due to CHIP intervention across the
baseline Total Cholesterol risk level categories are shown in Table 6.5. Analysis
indicated that there were significant differences in the mean change in Total
Cholesterol across the various Total Cholesterol risk level categories [F (4,279) =
13.494, p <.001].
Table 6.5: Change in Total Cholesterol Values across Baseline Biometric

Baseline Total Cholesterol

Number

Mean (M)

Standard Deviation (SD)

Optimal <4.00

25

.480

.518

Elevated (4.00-5.20)

111

.819

.472

High (5.21-5.99)

67

1.004

.566

Very High (6-6.99)

66

1.281

.752

Dangerous (>7.00)

15

1.480

.789
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Those participants with the greatest baseline cholesterol reading reported the
greatest lowering of their total cholesterol levels post intervention. (Figure 6.0)

Figure 6.0: The Distribution of Total Cholesterol Change across Baseline Total Cholesterol

When comparing the change in total cholesterol (post intervention) across the
various demographics, only the baseline total cholesterol registered a significant
difference. In this situation those participants with the greatest baseline cholesterol
reading reported the greatest lowering of their total cholesterol levels post
intervention.

Change in Low Density Lipoprotein (LDL) (mmol/L)
Gender
There was no significant differences between the mean change in LDL for the males
(M = .847, SD = .592) when compared with the females (M = .721, SD = .530).
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Age
The mean change in LDL values due to CHIP intervention across the various age
groupings are shown in Table 7.0. Post hoc tests indicated significance in the 40-59
and the 50-59 age categories [F (6,283) = 2.211, p <.042].

Table 7.0: Change in LDL Values across Age Groups

Age Group

Mean (M)

Standard Deviation (SD)

20-29

.675

.221

30-39

.866

.697

40-49

.583

.599

50-59

.918

.553

60-69

.747

.538

70-79

.691

.472

80+

.522

.530

The LDL change for the 0-49 and 70+ years age groups were similar but the 50-59
years age group recorded a significantly larger change (Figure 7.0).
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Figure 7.0: The Distribution of LDL Change across Age Categories

Marital Status
There were no significant differences in the mean change in LDL across the various
marital status categories. (Table 7.1)
Table 7.1: Change in LDL Values across Marital Status Groups

Marital Status

Mean (M)

Standard Deviation (SD)

Single

.593

.399

Married

.756

.555

Divorced

.978

.615

Widowed

.678

.635
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Family History of Cardiovascular Disease
There was no significant differences between the mean change in LDL for those with
(M = .780, SD = .342) or without (M = .745, SD = .563) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in LDL for those with
(M = .411, SD = .325) or without (M = .756, SD = .549) a family history of diabetes.
Baseline Exercise Levels
There were no significant differences in the mean change in LDL across the various
baseline exercise categories. (Table 7.2)
Table 7.2: Change in LDL Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

.770

.634

Mild

.717

.512

Moderate

.822

.549

Vigorous

.750

.478

Post Intervention Exercise Change
There were no significant differences in the mean change in LDL across the various
post intervention exercise change levels. (Table 7.3)
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Table 7.3: Change in LDL Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

.757

.655

-2

95

.792

.521

-1

105

.762

.525

0

48

.718

.634

1

1

1.900

2

1

.600

Baseline Smoking Status
There were no significant differences in the mean change in LDL across the various
baseline smoking status categories. (Table 7.4)
Table 7.4: Change in LDL Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

.785

.557

Ex-Smoker

.768

.599

Smoker

.400

.316

Live with Heavy Smoker

.700

.264
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Baseline Biometric: LDL
The mean changes in LDL values due to CHIP intervention across the baseline LDL
risk level categories are shown in Table 7.5. Analysis indicated that there were
significant differences in the mean change in LDL across the various LDL risk level
categories [F (3,283) = 19.054, p <.001].
Table 7.5: Change in LDL Values across Baseline Biometric

Baseline LDL

Number

Mean (M)

Standard Deviation (SD)

Optimal <2.5

64

.475

.387

Elevated 2.50-3.00

47

.583

.410

High 3.00-4.00

104

.804

.486

Very High >4.00

69

1.098

.672

Those participants with the greatest baseline LDL reading reported the greatest
lowering of their LDL levels post intervention. (Figure 7.1)

Figure 7.1: The Distribution of LDL Change across Baseline LDL
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When comparing the change in LDL levels (post intervention) across the various
demographics, only the baseline LDL and the 40-40 – 50-59 age categories
registered a significant difference. In this situation those participants with the
greatest baseline LDL reading reported the greatest lowering of their LDL levels post
intervention.

Change in High Density Lipoprotein (HDL) (mmol/L)
Gender
There was a significant difference between the mean change in HDL for the males
(M = .0928, SD = .140) when compared with the females (M = .147, SD = .187). The
female participants recorded a greater mean change in their high density lipoprotein
levels [t (282) = -2.536, p <.012].
Age
There were no significant differences in the mean change in HDL across the various
age groupings (Table 8.0).
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Table 8.0: Change in HDL Values across Age Groups

Age Group

Mean (M)

Standard Deviation (SD)

20-29

.170

.161

30-39

.060

.176

40-49

.136

.192

50-59

.162

.197

60-69

.115

.156

70-79

.120

.144

80+

.052

.182

Marital Status
There were no significant differences in the mean change in HDL across the various
marital status categories. (Table 8.1)
Table 8.1: Change in HDL Values across Marital Status Groups

Marital Status

Mean (M)

Standard Deviation (SD)

Single

.197

.196

Married

.118

.178

Divorced

.143

.165

Widowed

.162

.130
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Family History of Cardiovascular Disease
There was no significant differences between the mean change in HDL for those with
(M = .130, SD = .201) or without (M = .122, SD = .174) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in HDL for those with
(M = .083, SD = .213) or without (M = .123, SD = .174) a family history of diabetes.
Baseline Exercise Levels
There were no significant differences in the mean change in HDL across the various
baseline exercise levels. (Table 8.2)
Table 8.2: Change in HDL Values across Baseline Exercise levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

.109

.194

Mild

.117

.159

Moderate

.152

.170

Vigorous

.139

.178

Post Intervention Exercise Change
There were no significant differences in the mean change in HDL across the various
post intervention exercise change levels. (Table 8.3)
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Table 8.3: Change in HDL Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

.122

.161

-2

95

.126

.168

-1

105

.127

.186

0

48

.133

.172

1

1

-0.050

2

1

.190

Baseline Smoking Status
There were no significant differences in the mean change in HDL across the various
baseline smoking status categories. (Table 8.4)
Table 8.4: Change in HDL Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

.128

.153

Ex-Smoker

.143

.198

Smoker

-.035

.180

Live with Heavy Smoker

.124

.333
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Baseline Biometric: HDL
The mean changes in HDL values due to CHIP intervention across the baseline HDL
risk level categories are shown in Table 8.5. Analysis indicated that there were
significant differences in the mean change in HDL across the various HDL risk level
categories [F (2, 284) = 43.517, p <.001].
Table 8.5: Change in HDL Values across Baseline Biometric

Baseline HDL

Number

Mean (M)

Standard Deviation (SD)

<1.00

56

.014

.109

1.00 – 1.55

162

.111

.136

>1.55

66

.266

.211

Those participants with the greatest baseline HDL reading reported the greatest
lowering of their HDL levels post intervention. (Figure 8.0)

Figure 8.0: The Distribution of HDL Change across Baseline HDL
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When comparing the change in HDL levels (post intervention) across the various
demographics, only the baseline HDL, and gender categories registered a significant
difference. In this situation those participants with the greatest baseline HDL reading
reported the greatest lowering of their HDL levels post intervention. The female
participants also recorded a greater change than the male participants with their HDL
levels.

Change in Triglycerides (TRIG)
Gender
There was a significant difference between the mean change in TRIG for the males
(M = .295, SD = .575) when compared with the females (M = .100, SD = .619). [t
(282) = 2.591, p <.010]. The change in mean for males was greater than the females
post intervention.
Age
There were no significant differences in the mean change in TRIG across the various
age groupings. (Table 9.0)
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Table 9.0: Change in TRIG Values across Age Groups

Age Group

Mean (M)

Standard Deviation (SD)

20-29

.397

1.405

30-39

.182

.718

40-49

.240

.950

50-59

.105

.581

60-69

.207

.472

70-79

.098

.539

80+

.114

.280

Marital Status
There were no significant differences in the mean change in TRIG across the various
marital status categories (Table 9.1).
Table 9.1: Change in TRIG Values across Marital Status Groups

Marital Status

Mean (M)

Standard Deviation (SD)

Single

.002

.528

Married

.212

.633

Divorced

-.092

.464

Widowed

.055

.434
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Family History of Cardiovascular Disease
There was no significant differences between the mean change in TRIG for those
with (M = .274, SD = .458) or without (M = .164, SD = .652) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in TRIG for those
with (M = -.166, SD = .653) or without (M = .188, SD = .635) a family history of
diabetes.
Baseline Exercise Levels
There were no significant differences in the mean change in TRIG across the various
baseline exercise categories (Table 9.2).
Table 9.2: Change in TRIG Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

.208

.754

Mild

.158

.554

Moderate

.137

.579

Vigorous

.144

.239

Post Intervention Exercise Change
There were no significant differences in the mean change in TRIG across the various
post intervention exercise change levels (Table 9.3).
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Table 9.3: Change in TRIG Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

.262

1.017

-2

95

.233

.562

-1

105

.086

.558

0

48

.151

.514

1

1

.540

2

1

-.020

Baseline Smoking Status
There were no significant differences in the mean change in TRIG across the various
baseline smoking status categories. (Table 9.4)
Table 9.4: Change in TRIG Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

.159

.610

Ex-Smoker

.137

.587

Smoker

.588

.799

Live with Heavy Smoker

.192

.604
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Baseline Biometric: TRIG
The mean changes in TRIG values due to CHIP intervention across the baseline
TRIG risk level categories are shown in Table 9.5. Analysis indicated that there
were significant differences in the mean change in TRIG across the various TRIG
risk level categories [F (2,284) = 54.561, p <.001].
Table 9.5: Change in TRIG Values across Baseline Biometric

Baseline TRIG

Number

Mean (M)

Standard Deviation (SD)

Optimal <1.00

77

-.091

.230

Above Optimal 1.00-2.24

162

.091

.434

High >2.25

45

.888

.969

Those participants with the greatest baseline TRIG reading reported the greatest
lowering of their TRIG levels post intervention. (Figure 9.0)

Figure 9.0: The Distribution of HDL Change across Baseline HDL
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When comparing the change in TRIG levels (post intervention) across the various
demographics, only the baseline TRIG and gender registered a significant difference.
In this situation those participants with the greatest baseline t TRIG reading reported
the greatest lowering of their TRIG levels post intervention. The male participants
also scored a greater lowering of their TRIG levels post intervention than the female
participants.

Change in Glucose
Gender
There was no significant differences between the mean change in glucose for the
males (M = .674, SD = 1.681) when compared with the females (M = .391, SD =
.952).
Age
There were no significant differences in the mean change in glucose across the
various age groupings. (Table 10.0)
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Table 10.0: Change in Glucose Values across Age Groups

Age Group

Mean (M)

Standard Deviation (SD)

20-29

.050

.129

30-39

.241

.394

40-49

.455

1.184

50-59

.702

1.769

60-69

.445

1.073

70-79

.320

.718

80+

.166

.430

Marital Status
The mean changes in Glucose values due to CHIP intervention across the marital
status categories are shown in Table 10.1. Analysis indicated that there were
significant differences in the mean change in Glucose for the divorced marital status
only [F (3,270) = 6.498, p <.000].
Table 10.1: Change in Glucose Values across Marital Status Groups

Marital Status

Mean (M)

Standard Deviation (SD)

Single

.012

.364

Married

.440

.960

Divorced

1.750

3.615

Widowed

.135

.501
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Those participants who identified as being divorced had a greater mean change in
their glucose level post intervention than the other marital status categories. (Figure
10.0)

Figure 10.0: The Distribution of Glucose Change across Marital Status Groups

Family History of Cardiovascular Disease
There was no significant differences between the mean change in glucose for those
with (M = .407, SD = .545) or without (M = .550, SD = 1.388) a family history of
cardiovascular disease.
Family History of Diabetes
There was no significant differences between the mean change in glucose for those
with (M = .422, SD = .578) or without (M = .545, SD = 1.357) a family history of
diabetes.
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Baseline Exercise Levels
There were no significant differences in the mean change in glucose across the
various baseline exercise categories. (Table 10.2)
Table 10.2: Change in Glucose Values across Baseline Exercise Levels

Exercise Level

Mean (M)

Standard Deviation (SD)

None

.493

.785

Mild

.601

1.852

Moderate

.343

.665

Vigorous

.392

.695

Post Intervention Exercise Change
There were no significant differences in the mean change in glucose across the
various post intervention exercise change levels. (Table 10.3)
Table 10.3: Change in Glucose Values across Post Intervention Exercise Levels

Exercise Level

Number

Mean (M)

Standard Deviation (SD)

-3

28

.417

.734

-2

95

.469

1.093

-1

105

.582

1.688

0

48

.322

.659

1

1

.200

2

1

.600
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Baseline Smoking Status
There were no significant differences in the mean change in glucose across the
various baseline smoking status categories. (Table 10.4)
Table 10.4: Change in Glucose Values across Baseline Smoking Status

Smoking Status

Mean (M)

Standard Deviation (SD)

Non-Smoker

.423

.801

Ex-Smoker

.565

1.989

Smoker

.555

1.303

Live with Heavy Smoker

.522

.473

Baseline Biometric: Glucose
The mean changes in Glucose values due to CHIP intervention across the baseline
Glucose risk level categories are shown in Table 10.5. Analysis indicated that there
were significant differences in the mean change in Glucose across the various
baseline Glucose categories [F (2,284) = 73.384, p <.001].
Table 10.5: Change in Glucose Values across Baseline Biometric

Baseline Glucose

Number

Mean (M)

Standard Deviation (SD)

<5.6

147

.063

.460

5.6-7

105

.456

.446

>7

32

2.481

2.798
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Those participants with the greatest baseline glucose reading reported the greatest
lowering of their glucose levels post intervention. (Figure 10.1)

Figure 10.1: The Distribution of Glucose Change across Baseline Glucose

When comparing the change in glucose levels (post intervention) across the various
demographics, only the baseline glucose level and those participants with a divorced
marital status registered a significant difference. In this situation those participants
with the greatest baseline glucose reading reported the greatest lowering of their
glucose levels post intervention. In addition, those participants with a divorced
marital status had the greatest lowering of their glucose levels compared with the
rest of the participants.
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Chapter Six
Discussion of Results
The blood screening results of the Coronary Health Improvement Program (CHIP)
conducted in Hawera after the 30 days indicated considerable improvement in
participants biometrics overall. The chronic disease risk factors from baseline to
post-intervention all recorded improvement; from 4% (weight, BMI, systolic blood
pressure, diastolic blood pressure) to 23 % (low density lipoprotein). In particular a
minimum of 20% improvement was recorded for those participants who were in the
highest classification groups of total cholesterol (20%), LDL (24%), triglycerides
(30%) and glucose (26%).
Each of the chronic disease risk factors excluding total cholesterol were further
divided into risk factor levels according to the guidelines specified in The National
Cholesterol Education Program Adult Treatment Panel III classification system.
Total cholesterol was divided into 5 levels according to the Framingham study.
These risk factor levels provided a more descriptive analysis to be conducted to
analyse the movement of participants through the levels from baseline to post
intervention.
One of the effects of the 30 day intervention was to reduce the number of
participants classified in the higher risk factor levels. Out of 284 participants, 173
(60.9%) were classified in the top two risk factor levels for LDL. This figure
decreased by 33.5% to 78 participants post intervention. Participants that were
categorised in the top two levels for total cholesterol at baseline comprised of 28.5%
of the total participants. Remarkably this percentage decreased to just 6.68% post
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intervention giving an overall decrease of 28.8%. Whilst LDL and total cholesterol
recorded the most significant decreases in the percentage of participants in these
risk factor levels; reductions were recorded for the other biometrics. Participants
decreased by 16.5% in the highest factor levels for fasting plasma glucose. BPSYS
showed a decrease of 13.7%, HDL (10.9%), BPDIA (8.8%), TRIG (7.7%) and finally
BMI had a decrease of (2.5%).
All biometric changes when compared with the baseline figures recorded a
significant difference. However, participants with the highest baseline risk levels
recorded the greatest lowering of these levels post intervention.
Of the demographic factors studied, only gender, age and marital status had a
statistically significant impact on the change in some post intervention biometrics.
Regarding the impact of gender on the biometrics, male participants recorded a
higher level of change for their BMI score and triglyceride levels than the female
participants. However the female participants recorded a greater change to their
HDL levels than the males. The age group of 50-59 and 60-69 recorded a greater
change than the other age groupings for their BMI whereas the 40-49 and 50-59 age
categories recorded greater change in the LDL levels than the other age groups.
For glucose levels, those participants with a divorced marital status recorded a
higher change then participants from all the other marital status categories.

It is evident from the results above that CHIP conducted in Hawera was effective in
reducing the cardiovascular disease risk factors for participants. However it is also
important to understand the significance of these results when they are compared
with other programs.
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The overall mean change percentages of the biometrics in this case study was
compared to the results of the study of the CHIP programs which were conducted in
America (Rankin et al., 2012). The results of this community based program study
were comparable biometric reductions (BMI, BPDia, LDL and HDL) or better
reductions BMI had a 3.22% greater reduction, BPDia 0.18%, LDL 5.79% and HDL
3.96% than the American study (Rankin et al., 2012). These results indicate the
success of the Hawera based volunteer-delivered community- based CHIP program
in reducing the probability of developing cardiovascular disease.
It is difficult to make comparisons between the results of this Hawera case study and
that of the Ornish Spectrum and Pritikin lifestyle centres in their effectiveness in
reducing cardiovascular disease for their participants. Whilst all programs have
proven to be successful in their own way by reducing cardiovascular disease risk
factors, the mediums of measurement of change was vastly different and thus
difficult to draw direct comparisons between the programs. However it is important
to note that the results achieved by the CHIP program were accomplished in a
community based setting with a team of volunteers. The CHIP program is
undoubtedly an effective low cost alternative to the more costly residential based
programs.

This success of this program in reducing cardiovascular disease risk factors can in
part be attributed to the distinctive delivery of Dr T and his team. Unlike the
American programs, which were conducted by a different team of professionals each
time, the Hawera programs were run under the same leadership.
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As mentioned previously there are many key elements that are required to conduct a
successful community education program. Dr T and his team were proactive in
delivering a program with a style that would give participants every opportunity to
succeed in making healthy improvements to their lifestyle. The program had a
strong leadership team which was volunteer based, including Dr T who is well
respected in the community. In addition, his support team also consisted of previous
CHIP participants. The dynamics of this leadership team were a real asset for the
program delivery. Firstly, the participants felt they could put their trust in Dr T, and
they could also relate to those team members who had already completed this
program. Another important aspect in the delivery of this program was the focus on
practical applications for the theory that was being delivered via DVD. Participants
were given course material that they were required to complete and discuss as a
group. This process facilitated rich learning experiences for participants as they
were able to reflect and gather new ideas from each other. Practical cooking
demonstrations and tastings also gave participants the skills they needed to
implement healthy eating practices in their own homes.
Those involved in the CHIP programs in Hawera were self-selecting and their
willingness to sign up for the program indicated that they were motivated to learn and
make changes. Positive reinforcement was given verbally by the leadership team
throughout the meetings and the final blood screening results enabled participants to
see the positive improvements they had made to their health in those 30 days.
Finally, at the conclusion of the program the graduates were invited to join the CHIP
alumni which would be able to offer support and encouragement long term while
participants continued their healthy lifestyle journey. These factors contributed
significantly to the success of the CHIP program.
88

Whilst this study has aimed to assess the nature and effectiveness of the CHIP
program in Hawera in reducing cardiovascular disease risk factor it also provides
opportunity for greater research to be conducted in the area of preventative health.
A limitation of this study is assessing the results of the program beyond the 30 day
intervention. Many questions about the long term success of the program lie in the
ability to measure the effectiveness of participants in maintaining these lifestyle
changes in future years.
Further research should also be done to determine how compliant participants were
in applying the principles of health that were taught during the program and how
these compliance levels reflected in the final results.
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Appendices
Appendix 1 CHIP Questionnaire
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CHIP Lifestyle Evaluation
Name: ___________________________________________________ Today’s date: _____________
Address: __________________________________________________________________________
Phone (home) ________________ Business/Mobile: _______________________________________
Occupation: ___________________________

Your doctor: ________________________________

Age: ____________  Male  Female Marital status ___________________________________
One or both parents died before 60: Of heart disease? Yes No; Of diabetes? Yes  No
Check (X) if you have ever been told by a physician that you have any of the following:
Angina (Yr)? __________
Heart attack (yr)? _______
Angioplasty (Yr)? _______
Bypass (Yr)? ________
Heart failure (Yr)? ____
Blood clotting problem

Abnormal EKG (last 3
yrs)
Irregular heartbeats
Stroke (Yr)? ________
High blood pressure
highest ever? ____/____
High cholesterol
High triglycerides

Gall bladder trouble

Ulcers

Nervous breakdown
Kidney disease
Chronic bronchitis

Osteoarthritis
Rheumatoid arthritis
Overweight

Emphysema
Thyroid disorder

Gout
Diabetes

Please fill in the number of servings you eat or
drink weekly. If you don’t use, then mark “0”.
Please fill in every space.
Meat or shellfish _____ Salad dressings ________
Fowl or fish ________ Mayonnaise __________
Whole milk or 2% ___
Margarine ___________
Cottage cheese ______ Gravies _____________
Butter or cream _____
Soymeat/gluten _______
Cheese ____________ Soy milk _____________
Sour cream _________ Water _______________
Ice cream/ice milk ___ Alcohol _____________
Yoghurt ___________ Coffee/tea ___________
Liver/organ meats ___ Soft drinks ___________
Sausage/hot dogs ____ Sugar or sweets ________
Eggs ______________ Sugary desserts ________
Fried foods _________ Honey or syrup _______
Salty snacks _________ Jam/jelly/custard ______

OFFICE USE ONLY
health history: above:
Height _____ Wt. ______
Frame: Small
Medium Large
Ideal weight ___________
Blood pressure ____/____
Pulse (resting) _____/min.
Results of blood test

Rest & stress
Evening is the biggest
meal

Exercise

Eat little or no breakfast

None

(beyond everyday occupation)

Mild, at least 4x/wk
6 hrs sleep or
less/night
Sleep restlessly

Moderate, at least
4x/wk
Vigorous, at least 4x/wk

Suffer insomnia

Recommendation to improve your health based on tests and
Increase daily water to 8-10 glasses
Lose weight _____ kg
Reduce or eliminate salt
Avoid cholesterol intake (meats, sausages,
fowl, fish, egg yolks, liver, ice cream, cheese)
Reduce all dietary fat
Reduce refined sugar in diet
Increase aerobic/walking exercise
Substitute fruit, vegetables, potatoes for
processed, refined foods
Stop smoking
Eliminate caffeine drinks
Increase rest and relaxation
Make breakfast a bigger meal
See your doctor

95

Recommended program:
Weight management
Stress management
Stop smoking
Low cholesterol meal

management
Low salt cookery
Exercise/walking program

